REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,305 | -60.5% | 59,200 | +38.6% | 0.00% | – |
| Q3 2022 | $21,000 | -56.2% | 42,700 | -23.2% | 0.00% | – |
| Q2 2022 | $48,000 | -86.5% | 55,600 | -60.7% | 0.00% | – |
| Q1 2022 | $356,000 | -42.9% | 141,313 | -41.5% | 0.00% | – |
| Q4 2021 | $623,000 | -51.1% | 241,662 | -13.1% | 0.00% | – |
| Q3 2021 | $1,274,000 | -34.0% | 278,027 | -0.9% | 0.00% | – |
| Q2 2021 | $1,929,000 | +17.4% | 280,500 | +25.0% | 0.00% | – |
| Q1 2021 | $1,643,000 | +63.8% | 224,400 | +80.8% | 0.00% | – |
| Q4 2020 | $1,003,000 | -15.9% | 124,100 | +6.4% | 0.00% | – |
| Q3 2020 | $1,193,000 | +212.3% | 116,656 | +104.7% | 0.00% | – |
| Q2 2020 | $382,000 | +344.2% | 57,000 | +201.0% | 0.00% | – |
| Q1 2020 | $86,000 | +14.7% | 18,937 | +54.3% | 0.00% | – |
| Q4 2019 | $75,000 | -35.3% | 12,274 | -25.6% | 0.00% | – |
| Q3 2019 | $116,000 | +14.9% | 16,500 | -9.2% | 0.00% | – |
| Q4 2018 | $101,000 | -30.3% | 18,168 | -35.2% | 0.00% | – |
| Q1 2018 | $145,000 | -14.7% | 28,020 | -15.5% | 0.00% | – |
| Q4 2017 | $170,000 | – | 33,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |